RxDoctor Payments Data
★ My doctorsLook up a doctor →

Sidakpal Panaich, MD

Interventional Cardiology · Seattle, WANPI 1194955641

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $151,723 of the $213,827 with a category attached, or 71.0%. Edwards Lifesciences accounts for 65.1% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $160,179, more than ten times the $866 reported in 2019. Among interventional cardiology clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$213,827in general payments, 2019–2025

Across 394 payments — averaging $542.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$139K
  • Abbott$45K
  • Boston Scientific$20K
  • Stryker$4K
  • Baylis Medical Company Inc$1K
  • Abiomed$1K
  • plus $3K from 9 others
$942,116in research payments, 2019–2025

Across 81 payments — averaging $11,631 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Edwards Lifesciences$728K
  • Abbott$162K
  • W. L. Gore & Associates, Inc.$50K
  • Medtronic$2K

What the payments were for

  • Consulting fees$151,72371%
  • Speaking & faculty fees$15,1507%
  • Travel & lodging$30,40614%
  • Food & beverage$16,5488%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences171$139,113
Abbott90$45,496
Boston Scientific80$19,562
Stryker13$4,104
Baylis Medical Company Inc1$1,400
Abiomed9$1,082
Biosense Webster, Inc.3$942
Medtronic11$631
Inari Medical, Inc.8$555
W. L. Gore & Associates, Inc.2$305
Angiodynamics, Inc.1$254
Cardiovascular Systems Inc.2$166
Philips North America LLC1$128
Biotronik Inc.1$66
Novo Nordisk1$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$213,827 in reported general payments places this provider in the 90th percentile of 125 interventional cardiology providers in Washington.

See all interventional cardiology providers in Washington →

Medicare billing

Part B allowed, 2024
$435,815
Medicare patients
411
Services billed
1,289

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin22$21,825
EliquisApixaban18$20,509
EntrestoSacubitril/Valsartan19$14,196
BrilintaTicagrelor11$13,019
ClopidogrelClopidogrel Bisulfate66$963
Metoprolol Succinate58$872
Potassium Chloride19$560
Metolazone12$340
Furosemide47$303
Amlodipine Besylate25$214
Mupirocin22$191
Lisinopril16$166
Atorvastatin Calcium21$138
Losartan Potassium24$79
Spironolactone17$51

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Seattle

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →